Cleared Traditional

K961642 - MEDILOG MR95

K961642 is an FDA 510(k) clearance for MEDILOG MR95, manufactured by Oxford Instruments, Plc.. The device is a Class 2 Neurology device with product code GWQ cleared through the Traditional 510(k) pathway after a 263-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1997
Decision
263d
Days
Class 2
Risk

K961642 is an FDA 510(k) clearance for the MEDILOG MR95. Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by Oxford Instruments, Plc. (Clearwater, US). The FDA issued a Cleared decision on January 17, 1997 after a review of 263 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Oxford Instruments, Plc. devices

FDA 510(k) Submission Details - K961642

510(k) Number K961642 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 29, 1996
Decision Date January 17, 1997
Days to Decision 263 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
115d slower than avg
Panel avg: 148d · This submission: 263d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWQ Device Classification - Class 2, Special Controls

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 113
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K961642.
SATELLITE
K971331 · Nicolet Biomedical, Inc. · Jun 1997
MODEL 1320, NEUROLINK II NEUROMONITORING SYSTEM
K970942 · Physiometrix, Inc. · Jun 1997
GALILEO HALLEY
K970703 · Biosound Esaote, Inc. · May 1997
EQUINOX DIGITAL EEG SYSTEM
K962447 · Physiometrix, Inc. · Dec 1996
MODEL 1310 NEUROLINK NEUROMONITORING SYSTEM
K962157 · Physiometrix, Inc. · Nov 1996
CEEGRAPH TRAVELER AMBULATORY EEG RECORDER
K954954 · Bio-Logic Systems Corp. · Jan 1996